Middle East Sustained Release Excipients Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Middle East excipients market grows with chronic disease demand, polymer innovation, and healthcare investments.

Region:Middle East

Author(s):Shubham

Product Code:KRAE0462

Pages:86

Published On:December 2025

About the Report

Base Year 2024

Middle East Sustained Release Excipients Market Overview

  • The Middle East Sustained Release Excipients Market is valued at USD 1.6 billion, based on a five?year historical analysis. It is propelled by growing prevalence of chronic diseases such as diabetes, hypertension, and cancer, which drive demand for controlled drug delivery systems that improve patient compliance. Technological innovation in polymers, nanoformulations, and co-processed excipients further supports market growth by enhancing formulation stability, release profiles, and manufacturing efficiency.
  • Key players in this market include multinational suppliers such as BASF, Ashland, Roquette, JRS Pharma, and DFE Pharma, which dominate through specialized polymers and co-processed excipients. Countries like Saudi Arabia and the UAE lead in demand due to expanding pharmaceutical manufacturing, investments in generics and biosimilars, and reliance on imports owing to limited local production capacity.
  • Government-backed initiatives such as Saudi Arabia’s Vision 2030 are fostering healthcare diversification and pharmaceutical infrastructure development, encouraging private investment and supply of advanced excipients for controlled-release formulations. These strategic policies aim to reduce import dependence and support the region’s emergence as a pharmaceutical manufacturing hub.
Middle East Sustained Release Excipients Market Size

Middle East Sustained Release Excipients Market Segmentation

By Type:The sustained release excipients market is segmented into various types, including natural polymers, synthetic polymers, lipid-based excipients, and others. Among these, synthetic polymers are currently dominating the market due to their versatility and ability to provide tailored release profiles for various drug formulations. The increasing demand for customized drug delivery systems is driving the growth of synthetic polymers, as they can be engineered to meet specific therapeutic needs.

Middle East Sustained Release Excipients Market segmentation by Type.

By End-User:The market is also segmented by end-users, which include pharmaceutical companies, contract manufacturing organizations, research institutions, and others. Pharmaceutical companies are the leading end-users, driven by the increasing need for innovative drug formulations and the growing prevalence of chronic diseases. Their focus on developing advanced drug delivery systems is significantly contributing to the demand for sustained release excipients.

Middle East Sustained Release Excipients Market segmentation by End-User.

Middle East Sustained Release Excipients Market Competitive Landscape

The Middle East Sustained Release Excipients Market is characterized by a dynamic mix of regional and international players. Leading participants such as BASF SE, Evonik Industries AG, Ashland Global Holdings Inc., Dow Chemical Company, Croda International Plc, FMC Corporation, Merck KGaA, JRS Pharma, Roquette Frères, Ingredion Incorporated, Colorcon, HPM Global, Lubrizol Corporation, Sensient Technologies Corporation, Sentrachem contribute to innovation, geographic expansion, and service delivery in this space.

BASF SE

1865

Ludwigshafen, Germany

Evonik Industries AG

2000

Essen, Germany

Ashland Global Holdings Inc.

1924

Covington, Kentucky, USA

Dow Chemical Company

1897

Midland, Michigan, USA

Croda International Plc

1925

Goole, England

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Product Innovation Rate

Distribution Efficiency

Middle East Sustained Release Excipients Market Industry Analysis

Growth Drivers

  • Increasing Demand for Controlled Drug Delivery Systems:The Middle East is witnessing a significant rise in the demand for controlled drug delivery systems, driven by the need for improved therapeutic outcomes. In future, the region's healthcare expenditure is projected to reach approximately $250 billion, with a substantial portion allocated to innovative drug delivery technologies. This trend is further supported by the increasing prevalence of chronic diseases, which necessitate more effective treatment modalities, thereby boosting the sustained release excipients market.
  • Rising Prevalence of Chronic Diseases:Chronic diseases such as diabetes and cardiovascular disorders are on the rise in the Middle East, with the World Health Organization reporting that these conditions account for over 70% of deaths in the region. In future, the number of diabetes cases is expected to exceed 40 million, creating a pressing need for advanced pharmaceutical formulations. This surge in chronic disease prevalence is a key driver for the sustained release excipients market, as they enable better management of these conditions through controlled drug release.
  • Advancements in Pharmaceutical Formulations:The pharmaceutical sector in the Middle East is rapidly evolving, with significant investments in research and development. In future, R&D spending in the region is anticipated to surpass $7 billion, focusing on innovative excipients that enhance drug stability and bioavailability. These advancements are crucial for developing new formulations that meet the growing demand for effective therapies, thereby propelling the sustained release excipients market forward.

Market Challenges

  • Stringent Regulatory Requirements:The sustained release excipients market in the Middle East faces significant challenges due to stringent regulatory requirements imposed by health authorities. Compliance with Good Manufacturing Practices (GMP) is mandatory, and the approval process for new excipients can take several years. In future, the average time for regulatory approval is expected to remain around 16 months, which can hinder market entry for new products and slow down innovation in the sector.
  • High Production Costs of Excipients:The production costs associated with sustained release excipients are notably high, primarily due to the complex manufacturing processes and the need for high-quality raw materials. In future, the average cost of producing excipients is projected to be around $55 per kilogram, which can limit the profitability of manufacturers. This challenge is exacerbated by fluctuating raw material prices, making it difficult for companies to maintain competitive pricing in the market.

Middle East Sustained Release Excipients Market Future Outlook

The future of the sustained release excipients market in the Middle East appears promising, driven by ongoing advancements in drug formulation technologies and a growing emphasis on personalized medicine. As healthcare systems increasingly adopt innovative therapies, the demand for tailored drug delivery solutions is expected to rise. Additionally, collaborations between pharmaceutical companies and research institutions are likely to foster the development of novel excipients, enhancing the efficacy and safety of drug formulations in the region.

Market Opportunities

  • Expansion of Biopharmaceuticals:The biopharmaceutical sector in the Middle East is projected to grow significantly, with investments expected to reach $12 billion in future. This expansion presents a substantial opportunity for sustained release excipients, as they are essential for the effective delivery of biologics, enhancing their therapeutic potential and stability.
  • Increasing Focus on Personalized Medicine:The shift towards personalized medicine is gaining momentum in the Middle East, with healthcare providers increasingly tailoring treatments to individual patient needs. In future, the market for personalized medicine is expected to exceed $18 billion, creating opportunities for sustained release excipients that can be customized for specific patient profiles, thereby improving treatment outcomes.

Scope of the Report

SegmentSub-Segments
By Type

Natural Polymers

Synthetic Polymers

Lipid-based Excipients

Others

By End-User

Pharmaceutical Companies

Contract Manufacturing Organizations

Research Institutions

Others

By Application

Oral Drug Delivery

Injectable Drug Delivery

Transdermal Drug Delivery

Others

By Formulation Type

Tablets

Capsules

Suspensions

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Geography

GCC Countries

Levant Region

North Africa

Others

By Regulatory Compliance

FDA Approved Excipients

EMA Approved Excipients

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Food and Drug Administration of

Pharmaceutical Manufacturers

Biotechnology Companies

Contract Research Organizations (CROs)

Raw Material Suppliers

Pharmaceutical Packaging Companies

Industry Associations (e.g., Middle East Pharmaceutical Association)

Players Mentioned in the Report:

BASF SE

Evonik Industries AG

Ashland Global Holdings Inc.

Dow Chemical Company

Croda International Plc

FMC Corporation

Merck KGaA

JRS Pharma

Roquette Freres

Ingredion Incorporated

Colorcon

HPM Global

Lubrizol Corporation

Sensient Technologies Corporation

Sentrachem

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Middle East Sustained Release Excipients Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Middle East Sustained Release Excipients Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Middle East Sustained Release Excipients Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for controlled drug delivery systems
3.1.2 Rising prevalence of chronic diseases
3.1.3 Advancements in pharmaceutical formulations
3.1.4 Growing investments in R&D for excipients

3.2 Market Challenges

3.2.1 Stringent regulatory requirements
3.2.2 High production costs of excipients
3.2.3 Limited availability of raw materials
3.2.4 Competition from alternative drug delivery systems

3.3 Market Opportunities

3.3.1 Expansion of biopharmaceuticals
3.3.2 Increasing focus on personalized medicine
3.3.3 Development of novel excipients
3.3.4 Collaborations with research institutions

3.4 Market Trends

3.4.1 Shift towards sustainable excipients
3.4.2 Integration of technology in excipient manufacturing
3.4.3 Growth of online pharmaceutical sales
3.4.4 Increasing consumer awareness about drug formulations

3.5 Government Regulation

3.5.1 Compliance with GMP standards
3.5.2 Registration requirements for new excipients
3.5.3 Labeling and packaging regulations
3.5.4 Environmental regulations affecting production

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Middle East Sustained Release Excipients Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Middle East Sustained Release Excipients Market Segmentation

8.1 By Type

8.1.1 Natural Polymers
8.1.2 Synthetic Polymers
8.1.3 Lipid-based Excipients
8.1.4 Others

8.2 By End-User

8.2.1 Pharmaceutical Companies
8.2.2 Contract Manufacturing Organizations
8.2.3 Research Institutions
8.2.4 Others

8.3 By Application

8.3.1 Oral Drug Delivery
8.3.2 Injectable Drug Delivery
8.3.3 Transdermal Drug Delivery
8.3.4 Others

8.4 By Formulation Type

8.4.1 Tablets
8.4.2 Capsules
8.4.3 Suspensions
8.4.4 Others

8.5 By Distribution Channel

8.5.1 Direct Sales
8.5.2 Distributors
8.5.3 Online Sales
8.5.4 Others

8.6 By Geography

8.6.1 GCC Countries
8.6.2 Levant Region
8.6.3 North Africa
8.6.4 Others

8.7 By Regulatory Compliance

8.7.1 FDA Approved Excipients
8.7.2 EMA Approved Excipients
8.7.3 Others

9. Middle East Sustained Release Excipients Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Product Innovation Rate
9.2.7 Distribution Efficiency
9.2.8 Pricing Strategy
9.2.9 Brand Recognition
9.2.10 Operational Efficiency

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 BASF SE
9.5.2 Evonik Industries AG
9.5.3 Ashland Global Holdings Inc.
9.5.4 Dow Chemical Company
9.5.5 Croda International Plc
9.5.6 FMC Corporation
9.5.7 Merck KGaA
9.5.8 JRS Pharma
9.5.9 Roquette Frères
9.5.10 Ingredion Incorporated
9.5.11 Colorcon
9.5.12 HPM Global
9.5.13 Lubrizol Corporation
9.5.14 Sensient Technologies Corporation
9.5.15 Sentrachem

10. Middle East Sustained Release Excipients Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Procurement Processes
10.1.3 Supplier Selection Criteria
10.1.4 Contract Management Practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends in Pharmaceutical Infrastructure
10.2.2 Energy Consumption Patterns
10.2.3 Budgeting for Sustainable Practices
10.2.4 Corporate Social Responsibility Initiatives

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges in Sourcing Quality Excipients
10.3.2 Issues with Regulatory Compliance
10.3.3 Supply Chain Disruptions
10.3.4 Cost Management Concerns

10.4 User Readiness for Adoption

10.4.1 Awareness of Sustained Release Technologies
10.4.2 Training and Support Needs
10.4.3 Adoption Barriers
10.4.4 Feedback Mechanisms

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Case Studies of Successful Implementations
10.5.3 Future Use Case Opportunities
10.5.4 Long-term Partnerships and Collaborations

11. Middle East Sustained Release Excipients Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Analysis
9.1.3 Packaging Strategies

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership Considerations

12.2 Partnerships Evaluation


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability Strategies


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Industry reports from regional pharmaceutical and chemical associations
  • Market analysis publications focusing on excipients and drug delivery systems
  • Government publications and trade statistics related to pharmaceutical manufacturing

Primary Research

  • Interviews with R&D heads at pharmaceutical companies utilizing sustained release excipients
  • Surveys with procurement managers in the pharmaceutical sector
  • Field interviews with regulatory affairs specialists regarding excipient compliance

Validation & Triangulation

  • Cross-validation of data from multiple industry sources and expert opinions
  • Triangulation of market size estimates from sales data and production statistics
  • Sanity checks through expert panel discussions and feedback loops

Phase 2: Market Size Estimation1

Top-down Assessment

  • Analysis of total pharmaceutical market size in the Middle East and excipient share
  • Segmentation by therapeutic areas and excipient types used in sustained release formulations
  • Incorporation of growth trends in the pharmaceutical sector and regulatory impacts

Bottom-up Modeling

  • Volume estimates based on production capacities of key pharmaceutical manufacturers
  • Cost analysis of sustained release excipients based on supplier pricing
  • Calculation of market size using volume x price for various excipient categories

Forecasting & Scenario Analysis

  • Multi-variable forecasting using historical growth rates and market drivers
  • Scenario analysis based on potential regulatory changes and market entry of new players
  • Development of baseline, optimistic, and pessimistic market projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Manufacturers150R&D Managers, Production Heads
Regulatory Bodies50Regulatory Affairs Officers, Compliance Managers
Raw Material Suppliers100Sales Managers, Product Development Specialists
Contract Research Organizations (CROs)80Project Managers, Clinical Research Coordinators
End-users in Formulation Development70Formulation Scientists, Quality Assurance Managers

Frequently Asked Questions

What is the current value of the Middle East Sustained Release Excipients Market?

The Middle East Sustained Release Excipients Market is valued at approximately USD 1.6 billion, driven by the increasing prevalence of chronic diseases and the demand for controlled drug delivery systems that enhance patient compliance.

What factors are driving the growth of the sustained release excipients market in the Middle East?

Who are the major players in the Middle East Sustained Release Excipients Market?

What types of excipients are included in the sustained release excipients market?

Other Regional/Country Reports

UAE Sustained Release Excipients MarketKSA Sustained Release Excipients MarketGlobal Sustained Release Excipients Market

Indonesia Sustained Release Excipients Market

Malaysia Sustained Release Excipients Market

APAC Sustained Release Excipients Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022